Xcout Intel
Kinoxis Therapeutics
Kinoxis Therapeutics Pty Ltd is an Australian-based, clinical-stage biotechnology company that develops first-in-class therapeutics targeting ALOX15 to address central nervous system (CNS) diseases.
Subscribe to see Kinoxis Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Kinoxis Therapeutics at a glance
Kinoxis Therapeutics is a drug discovery company headquartered in Australia. Xcout tracks 11 named people at Kinoxis Therapeutics, including Cameron Jones (CFO & Company Secretary).
Kinoxis Therapeutics leadership
- Cameron JonesCFO & Company Secretary
- Dr Peter DevineChair
- Hugh AlsopChief Executive Officer, Co-Founder
- Michael BowenChief Scientific Officer, Co-Founder
- Tiina AhveninenVice President, Clinical Research
- Tristan ReekieVice President, Discovery Research
5 more named people on record for Kinoxis Therapeutics, with roles, board committees and tenure — see the full roster →
Kinoxis Therapeutics competitors
A few of Kinoxis Therapeutics's closest competitors — see the full list of competitors and alternatives →
Goldenrod Therapeutics, Inc. is a biotechnology innovator based in Houston, Texas, developing treatments for brain inflammation and PDE4B inhibitors for neurological conditions and substance use disorder.
Stellate Therapeutics is a pre-clinical stage biotechnology company that develops small molecules produced by human gut bacteria into therapies for neurodegenerative and age-related neurological diseases.
Senexis Limited is a privately held biotechnology company founded in 2001 that focuses on small-molecule drug development and life sciences research.
Nura Bio Inc. is a privately held biopharmaceutical company headquartered in South San Francisco, California, founded in 2018 to develop novel treatments for neurological diseases.
Omniox, Inc. is an early-stage biopharmaceutical company located in San Francisco, California, focused on developing new medicines for hypoxic diseases.
Gesynta Pharma AB is a pharmaceutical manufacturing company headquartered in Stockholm, Sweden, dedicated to developing innovative anti-inflammatory and pain-relieving therapies targeting the mPGES-1 enzyme.
Get Kinoxis Therapeutics's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Kinoxis Therapeutics in Xcout Intel
- 11 named people with titles, LinkedIn and board committees
- The full competitor set, tracking, exports and API access